Governance
Investors

Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

Innovating targeting

Philogen is a Swiss-Italian biotechnology company, founded in 1996 and listed on the Italian Stock Exchange, with a mission to innovate the treatment of cancer and other serious conditions

 

Mar 20 2023
, ,

20 marzo 2023 – Aggiornamento sul programma di acquisto di azioni proprie

More details
Mar 17 2023
, ,

Philogen to attend the 74th Mosbacher Kolloquium in Mosbach/Baden, on March 23-25, 2023

Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 23rd of March 2023 entitled “Novel developments on immunocytokines” Follow the link for more...
Mar 17 2023
, ,

Philogen to attend AACR Annual Meeting in Orlando on April 14-18, 2023

Prof. Dr. Dario Neri (CEO and CSO), Dr. Covelli (CMO), Dr. Dakhel, Dr. De Luca, Dr. Cazzamalli, Dr. Galbiati, Dr. Puca, Matilde Bocci, Eleonora Prodi, Sara...
Mar 17 2023
,

Philogen to attend Mid & Small | London 2023 Conference on April 20, 2023

Prof. Dario Neri (CEO and CSO), and Emanuele Puca (Investor Relations) will participate at the event to present Philogen and its programs to the financial community.
Mar 17 2023
, ,

Philogen to attend 19th EADO Congress on April 20-22, 2023

Dr. Covelli (CMO), Dr. Elia, Dr. Ravenni, and Dr. Nadal will participate at the event in Rome. The dermato-oncology team from St. Gallen will give a presentation...
Mar 17 2023
, ,

Philogen to attend the 19th PEGSBOSTON in Boston, on May 15-19, 2023

Prof. Dr. Dario Neri (CEO and CSO), is giving a KEYNOTE presentation on the 18th of May 2023 entitled “Antibody-Cytokine Fusions for the Treatment of Difficult-to-Cure...
Mar 17 2023
, ,

Philogen to attend the Lund Spring Symposium in Lund on May 22-24, 2023

Prof. Dr. Dario Neri (CEO and CSO) is participating as a speaker at Lund Spring Symposium. Follow the link for more details.  
Mar 17 2023
, ,

Philogen to attend the Immuno-Oncology Summit Europe 2023 in London, on June 20-22, 2023

Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 20th of June 2023 entitled “Antibody-Cytokine Fusions Targeting the Tumor Microenvironment: Lessons...
Mar 17 2023
,

Philogen to attend Stifel European Healthcare Summit in Bordeaux on June 28-30, 2023

Prof. Dario Neri (CEO and CSO), and Emanuele Puca (Investor Relations) will participate at the event and will be available for 1o1 meetings with Investors.
Mar 13 2023
, ,

13 marzo 2023 – Aggiornamento sul programma di acquisto di azioni proprie

More details

OUR SCIENCES

Learn about our strategy

PIPELINE

Learn more about our pipeline

WORK WITH US

Look at open positions